Table 1 Patient demographics and clinical characteristics

Sex

Male

22

Female

15

Median age, years

58

Range

27-77

ECOG performance status

0

20

1

17

Tumor biopsy sites

Liver

15

Abdominal wall

9

Rectum/vaginal wall

4

Scalp

2

Lymph node

5

Prior lines of treatment

2-3

18 (51%)

≥4

17 (49%)

Prior treatment

Bevacizumab

15 (43%)

Cetuximab

15 (43%)

Baseline organ function

AST (U/L)

34.6 ± 22.4

ALT (U/L)

23.5 ± 10.9

Total bilirubin (μmol/L)

10.1 ± 5.8

Creatinine (μmol/L)

66.9 ± 27.0